Literature DB >> 16528574

Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma.

Tsukasa Wada1, Kiyoshi Kuroda, Yuki Yoshida, Kuniaki Ogasawara, Akira Ogawa, Shigeatsu Endo.   

Abstract

We investigated the relationship between inflammatory and anti-inflammatory cytokines in the pathogenesis of chronic subdural hematoma (CSDH) by measuring the plasma and subdural fluid levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10). The levels of IL-6, IL-8 and IL-10 were measured in the subdural fluid obtained from 34 patients with CSDH, using the enzyme-linked immunosorbent assay. The patients were classified into a high IL-10 group and a low IL-10 group according to the level of IL-10 in their subdural fluid samples. The subdural fluid levels of IL-6 and IL-8 were significantly higher in the high IL-10 group than in the low IL-10 group (P<0.05). A tendency for the patients in the low IL-10 group to show the separated or layer type of pattern on the CT scans was noted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528574     DOI: 10.1007/s10143-006-0019-7

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  20 in total

1.  Pathogenesis of chronic subdural hematoma. Experimental studies.

Authors:  C L GOODELL; J MEALEY
Journal:  Arch Neurol       Date:  1963-04

2.  Inflammatory cytokines locally elevated in chronic subdural haematoma.

Authors:  M Suzuki; S Endo; K Inada; A Kudo; A Kitakami; K Kuroda; A Ogawa
Journal:  Acta Neurochir (Wien)       Date:  1998       Impact factor: 2.216

Review 3.  Chronic subdural hematomas: a review.

Authors:  T M Markwalder
Journal:  J Neurosurg       Date:  1981-05       Impact factor: 5.115

Review 4.  On the question of a subdural space.

Authors:  D E Haines
Journal:  Anat Rec       Date:  1991-05

5.  Relationship between drainage catheter location and postoperative recurrence of chronic subdural hematoma after burr-hole irrigation and closed-system drainage.

Authors:  H Nakaguchi; T Tanishima; N Yoshimasu
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

Review 6.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

7.  Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot.

Authors:  S Nomura; S Kashiwagi; H Fujisawa; H Ito; K Nakamura
Journal:  J Neurosurg       Date:  1994-12       Impact factor: 5.115

8.  Tissue-type plasminogen activator in the chronic subdural hematoma.

Authors:  H Ito; K Saito; S Yamamoto; T Hasegawa
Journal:  Surg Neurol       Date:  1988-09

9.  The presence of tumour necrosis factor in CSF and plasma after severe head injury.

Authors:  S A Ross; M I Halliday; G C Campbell; D P Byrnes; B J Rowlands
Journal:  Br J Neurosurg       Date:  1994       Impact factor: 1.596

10.  Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation.

Authors:  H Fujisawa; H Ito; S Kashiwagi; S Nomura; M Toyosawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

View more
  13 in total

1.  Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study.

Authors:  Milo Stanisic; Ansgar Oddne Aasen; Are Hugo Pripp; Karl-Fredrik Lindegaard; Jon Ramm-Pettersen; Staale Petter Lyngstadaas; Jugoslav Ivanovic; Ane Konglund; Eivind Ilstad; Tiril Sandell; Omar Ellingsen; Terje Sæhle
Journal:  Inflamm Res       Date:  2012-04-19       Impact factor: 4.575

Review 2.  The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor.

Authors:  Ralf Weigel; Lothar Schilling; Joachim K Krauss
Journal:  Geroscience       Date:  2022-04-23       Impact factor: 7.581

3.  Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome.

Authors:  Olufemi Emmanuel Idowu; Stevens Olaide Oyeleke; Julius Mautin Vitowanu
Journal:  Eur J Trauma Emerg Surg       Date:  2021-04-11       Impact factor: 3.693

Review 4.  Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.

Authors:  Ellie Edlmann; Susan Giorgi-Coll; Peter C Whitfield; Keri L H Carpenter; Peter J Hutchinson
Journal:  J Neuroinflammation       Date:  2017-05-30       Impact factor: 8.322

Review 5.  Statins in conditions other than hypocholesterolemic effects for chronic subdural hematoma therapy, old drug, new tricks?

Authors:  Hai Zou; Xing-Xing Zhu; Ya-Hui Ding; Guo-Bing Zhang; Yu Geng; Dong-Sheng Huang
Journal:  Oncotarget       Date:  2017-04-18

6.  Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial.

Authors:  Angelos G Kolias; Ellie Edlmann; Eric P Thelin; Diederik Bulters; Patrick Holton; Nigel Suttner; Kevin Owusu-Agyemang; Yahia Z Al-Tamimi; Daniel Gatt; Simon Thomson; Ian A Anderson; Oliver Richards; Peter Whitfield; Monica Gherle; Karen Caldwell; Carol Davis-Wilkie; Silvia Tarantino; Garry Barton; Hani J Marcus; Aswin Chari; Paul Brennan; Antonio Belli; Simon Bond; Carole Turner; Lynne Whitehead; Ian Wilkinson; Peter J Hutchinson
Journal:  Trials       Date:  2018-12-04       Impact factor: 2.279

7.  Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase.

Authors:  Ellie Edlmann; Eric P Thelin; Karen Caldwell; Carole Turner; Peter Whitfield; Diederik Bulters; Patrick Holton; Nigel Suttner; Kevin Owusu-Agyemang; Yahia Z Al-Tamimi; Daniel Gatt; Simon Thomson; Ian A Anderson; Oliver Richards; Monica Gherle; Emma Toman; Dipankar Nandi; Phillip Kane; Beatrice Pantaleo; Carol Davis-Wilkie; Silvia Tarantino; Garry Barton; Hani J Marcus; Aswin Chari; Antonio Belli; Simon Bond; Rafael Gafoor; Sarah Dawson; Lynne Whitehead; Paul Brennan; Ian Wilkinson; Angelos G Kolias; Peter J A Hutchinson
Journal:  Sci Rep       Date:  2019-04-10       Impact factor: 4.379

8.  Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial.

Authors:  Rongcai Jiang; Dong Wang; Wai Sang Poon; Yi Cheng Lu; Xin Gang Li; Shi Guang Zhao; Ren Zhi Wang; Chao You; Xian Rui Yuan; Jian Min Zhang; Hua Feng; Zhou Fei; Xin Guang Yu; Yuan Li Zhao; Jin Hu; De Zhi Kang; Ru Tong Yu; Guo Dong Gao; Xi De Zhu; Tao Sun; Jie He Hao; Xian Zhi Liu; Ning Su; Shu Yuan Yue; Jian Ning Zhang
Journal:  Trials       Date:  2015-11-18       Impact factor: 2.279

Review 9.  Chronic subdural hematoma.

Authors:  Yad R Yadav; Vijay Parihar; Hemant Namdev; Jitin Bajaj
Journal:  Asian J Neurosurg       Date:  2016 Oct-Dec

10.  Association between biomarkers and clinical characteristics in chronic subdural hematoma patients assessed with lasso regression.

Authors:  Are Hugo Pripp; Milo Stanišić
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.